Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
OceanaGold CEO Gerard Bond to retire in Q2 2027

OceanaGold CEO Gerard Bond to retire in Q2 2027

BitgetBitget2026/09/23 21:00
  • OceanaGold CEO Gerard Bond notified the board he will retire in April 2027, marking a management transition in Q2 2027.
  • The board engaged Spencer Stuart to run a search process, weighing internal and external candidates for the next CEO.
  • Bond will serve as special adviser to the board and the incoming CEO for six months following his departure.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OceanaGold Corporation published the original content used to generate this news brief via CNW (Ref. ID: 202609231700CANADANWCANADAPR_C5858) on September 23, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Sixth increase in six years! Disney(DIS.US) raises the monthly fee for Disney+ ad-free version by 13% to $21.49.

Walt Disney Company (DIS.US) is raising subscription prices for several of its streaming services in the U.S. market, marking the sixth price increase in six years, as the company aims to boost the profitability of its streaming business, which is crucial for Disney's future.

智通财经2026/09/24 06:51

Johnson & Johnson (JNJ.US) Tarlatamab to be included in China's priority review, aimed at inhibiting tumor formation and growth

On September 24, according to the CDE website, Johnson & Johnson’s (JNJ.US) talquetamab (Chinese brand name: Tuolike) is proposed to be included in priority review.

智通财经2026/09/24 06:51
Johnson & Johnson (JNJ.US) Tarlatamab to be included in China's priority review, aimed at inhibiting tumor formation and growth

Australian stocks closed down 0.72%

格隆汇2026/09/24 06:27

160 Threshold Revisited: Risk of Yen Intervention Rekindled, U.S. Stance Becomes Key Variable

The risk of yen intervention has once again become a focal point in the market.

智通财经2026/09/24 06:26